Tyler Korman's most recent trade in eXoZymes Inc. was a trade of 750 COMMON STOCK done at an average price of $10.0 . Disclosure was reported to the exchange on April 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eXoZymes Inc | Tyler Korman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 09 Apr 2026 | 750 | 729,873 | - | 10.0 | 7,530 | COMMON STOCK |
| eXoZymes Inc | Tyler Korman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 09 Apr 2026 | 750 | 729,123 | - | 10.5 | 7,894 | COMMON STOCK |
| eXoZymes Inc | Tyler Korman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 8.44 per share. | 01 Apr 2026 | 5,332 | 730,623 | - | 8.4 | 45,002 | COMMON STOCK |
| eXoZymes Inc | Tyler Korman | Vice President, Research | Grant, award, or other acquisition of securities at price $ 12.54 per share. | 13 Jun 2025 | 2,990 | 725,291 | - | 12.5 | 37,495 | Common Stock |